345 related articles for article (PubMed ID: 29331564)
1. Direct renin inhibition is not enough to prevent reactive oxygen species generation and vascular dysfunction in renovascular hypertension.
Martins-Oliveira A; Guimaraes DA; Ceron CS; Rizzi E; Oliveira DMM; Tirapelli CR; Casarini DE; Fernandes FB; Pinheiro LC; Tanus-Santos JE
Eur J Pharmacol; 2018 Feb; 821():97-104. PubMed ID: 29331564
[TBL] [Abstract][Full Text] [Related]
2. Contrasting effects of aliskiren versus losartan on hypertensive vascular remodeling.
Martins-Oliveira A; Castro MM; Oliveira DM; Rizzi E; Ceron CS; Guimaraes D; Reis RI; Costa-Neto CM; Casarini DE; Ribeiro AA; Gerlach RF; Tanus-Santos JE
Int J Cardiol; 2013 Aug; 167(4):1199-205. PubMed ID: 22483258
[TBL] [Abstract][Full Text] [Related]
3. Despite similar reduction of blood pressure and renal ANG II and ET-1 levels aliskiren but not losartan normalizes albuminuria in hypertensive Ren-2 rats.
Vaňourková Z; Kramer HJ; Husková Z; Cervenka L; Vaněčková I
Physiol Res; 2010; 59(3):339-345. PubMed ID: 20666571
[TBL] [Abstract][Full Text] [Related]
4. Direct renin inhibitor prevents and ameliorates insulin resistance, aortic endothelial dysfunction and vascular remodeling in fructose-fed hypertensive rats.
Chou CL; Pang CY; Lee TJ; Fang TC
Hypertens Res; 2013 Feb; 36(2):123-8. PubMed ID: 22895064
[TBL] [Abstract][Full Text] [Related]
5. Hemodynamic and hormonal changes to dual renin-angiotensin system inhibition in experimental hypertension.
Moniwa N; Varagic J; Ahmad S; VonCannon JL; Simington SW; Wang H; Groban L; Brosnihan KB; Nagata S; Kato J; Kitamura K; Gomez RA; Lopez ML; Ferrario CM
Hypertension; 2013 Feb; 61(2):417-24. PubMed ID: 23232645
[TBL] [Abstract][Full Text] [Related]
6. Persistent antihypertensive effect of aliskiren is accompanied by reduced proteinuria and normalization of glomerular area in Ren-2 transgenic rats.
Rakusan D; Kujal P; Kramer HJ; Husková Z; Vanourková Z; Vernerová Z; Mrázová I; Thumová M; Cervenka L; Vanecková I
Am J Physiol Renal Physiol; 2010 Oct; 299(4):F758-66. PubMed ID: 20668096
[TBL] [Abstract][Full Text] [Related]
7. Losartan reduces monocyte chemoattractant protein-1 expression in aortic tissues of 2K1C hypertensive rats.
Xie QY; Sun M; Yang TL; Sun ZL
Int J Cardiol; 2006 Jun; 110(1):60-6. PubMed ID: 16242797
[TBL] [Abstract][Full Text] [Related]
8. AT1 antagonism and renin inhibition in mice: pivotal role of targeting angiotensin II in chronic kidney disease.
Fraune C; Lange S; Krebs C; Hölzel A; Baucke J; Divac N; Schwedhelm E; Streichert T; Velden J; Garrelds IM; Danser AH; Frenay AR; van Goor H; Jankowski V; Stahl R; Nguyen G; Wenzel UO
Am J Physiol Renal Physiol; 2012 Oct; 303(7):F1037-48. PubMed ID: 22791343
[TBL] [Abstract][Full Text] [Related]
9. Renin inhibitor aliskiren improves impaired nitric oxide bioavailability and protects against atherosclerotic changes.
Imanishi T; Tsujioka H; Ikejima H; Kuroi A; Takarada S; Kitabata H; Tanimoto T; Muragaki Y; Mochizuki S; Goto M; Yoshida K; Akasaka T
Hypertension; 2008 Sep; 52(3):563-72. PubMed ID: 18645051
[TBL] [Abstract][Full Text] [Related]
10. The direct renin inhibitor aliskiren improves vascular remodelling in transgenic rats harbouring human renin and angiotensinogen genes.
Savoia C; Arrabito E; Parente R; Sada L; Madaro L; Nicoletti C; Zezza L; Alonzo A; Rubattu S; Michelini S; Muller DN; Volpe M
Clin Sci (Lond); 2013 Aug; 125(4):183-9. PubMed ID: 23438195
[TBL] [Abstract][Full Text] [Related]
11. [The future of renin inhibition].
Uresin AY; Baran E
Turk Kardiyol Dern Ars; 2009 Oct; 37 Suppl 7():32-8. PubMed ID: 20019475
[TBL] [Abstract][Full Text] [Related]
12. Beneficial cardiac effects of the renin inhibitor aliskiren in spontaneously hypertensive rats.
van Esch JH; Moltzer E; van Veghel R; Garrelds IM; Leijten F; Bouhuizen AM; Danser AH
J Hypertens; 2010 Oct; 28(10):2145-55. PubMed ID: 20625318
[TBL] [Abstract][Full Text] [Related]
13. Direct renin inhibition in a rat model of chronic allograft injury.
Rusai K; Schmaderer C; Hermans JJ; Lutz J; Heemann U; Baumann M
Transplantation; 2011 Nov; 92(9):999-1004. PubMed ID: 21956196
[TBL] [Abstract][Full Text] [Related]
14. Handle region peptide counteracts the beneficial effects of the Renin inhibitor aliskiren in spontaneously hypertensive rats.
van Esch JH; van Veghel R; Garrelds IM; Leijten F; Bouhuizen AM; Danser AH
Hypertension; 2011 Apr; 57(4):852-8. PubMed ID: 21321303
[TBL] [Abstract][Full Text] [Related]
15. Direct inhibition of renin as a cardiovascular pharmacotherapy: focus on aliskiren.
Sepehrdad R; Frishman WH; Stier CT; Sica DA
Cardiol Rev; 2007; 15(5):242-56. PubMed ID: 17700383
[TBL] [Abstract][Full Text] [Related]
16. Aliskiren enhances the protective effects of valsartan against cardiovascular and renal injury in endothelial nitric oxide synthase-deficient mice.
Yamamoto E; Kataoka K; Dong YF; Nakamura T; Fukuda M; Tokutomi Y; Matsuba S; Nako H; Nakagata N; Kaneko T; Ogawa H; Kim-Mitsuyama S
Hypertension; 2009 Sep; 54(3):633-8. PubMed ID: 19597038
[TBL] [Abstract][Full Text] [Related]
17. Aliskiren inhibits experimental venous thrombosis in two-kidney one- clip hypertensive rats.
Hermanowicz JM; Hermanowicz A; Buczko P; Leszczynska A; Tankiewicz-Kwedlo A; Mogielnicki A; Buczko W
Thromb Res; 2013 Jan; 131(1):e39-44. PubMed ID: 23174623
[TBL] [Abstract][Full Text] [Related]
18. Effect of the direct Renin inhibitor aliskiren, the Angiotensin receptor blocker losartan, or both on left ventricular mass in patients with hypertension and left ventricular hypertrophy.
Solomon SD; Appelbaum E; Manning WJ; Verma A; Berglund T; Lukashevich V; Cherif Papst C; Smith BA; Dahlöf B;
Circulation; 2009 Feb; 119(4):530-7. PubMed ID: 19153265
[TBL] [Abstract][Full Text] [Related]
19. Renin inhibition ameliorates renal damage through prominent suppression of both angiotensin I and II in human renin angiotensinogen transgenic mice with high salt loading.
Yoshida S; Ishizawa K; Ayuzawa N; Ueda K; Takeuchi M; Kawarazaki W; Fujita T; Nagase M
Clin Exp Nephrol; 2014 Aug; 18(4):593-9. PubMed ID: 24154707
[TBL] [Abstract][Full Text] [Related]
20. Local renin-angiotensin system mediates endothelial dilator dysfunction in aging arteries.
Flavahan S; Chang F; Flavahan NA
Am J Physiol Heart Circ Physiol; 2016 Sep; 311(3):H849-54. PubMed ID: 27422988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
